Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2010
10/07/2010WO2010111842A1 Antigenic determinants recognized by anti-human death receptor dr5 monoclonal antibody ad5-10, derivatives and uses thereof
10/07/2010WO2010111787A1 Highly acidic chitosan-nucleic acid polyplex compositions
10/07/2010WO2010100437A9 Production of protein
10/07/2010WO2010092598A3 Plant regeneration from immature embryos of jatropha curcas l.
10/07/2010WO2010085162A3 Expression cassettes, T-DNA molecules, plant expression vectors, transgenic plant cells as well as the use thereof in the production of a vaccine
10/07/2010WO2010080985A8 Compositions and methods for induced brown fat differentiation
10/07/2010WO2010079510A3 Anti-rhd monoclonal antibodies
10/07/2010WO2010065578A3 POLYPEPTIDES COMPRISING Fc FRAGMENTS OF IMMUNOGLOBULIN G (IgG) AND METHODS OF USING THE SAME
10/07/2010WO2010064851A3 Mtor-targeted sirna having an interspecific cross reaction, recombination vector containing same, and pharmaceutical composition containing same
10/07/2010WO2010059965A3 Methods and compositions for generating self attenuating genetic circuitry
10/07/2010WO2010054649A3 Method for the oral/mucosal vaccination by means of recombinant yeasts
10/07/2010WO2010039543A3 Self delivering bio-labile phosphate protected pro-oligos for oligonucleotide based therapeutics and mediating rna interference
10/07/2010WO2010036969A3 Genetic markers for assessing risk of developing schizophrenia
10/07/2010WO2010036965A3 Genetic markers of schizophrenia endophenotypes
10/07/2010WO2010011890A3 Cancer peptide therapeutics
10/07/2010WO2006036698A9 Modification of plant lignin content
10/07/2010WO2001079455A9 Kv10.1, A NOVEL VOLTAGE-GATED POTASSIUM CHANNEL FROM HUMAN BRAIN
10/07/2010US20100257638 Zinc finger nuclease-mediated homologous recombination
10/07/2010US20100257637 Transgenic Plant with Increased Stress Tolerance and Yield
10/07/2010US20100257636 Plant biochemical systems and uses thereof
10/07/2010US20100257635 Use of a seed specific promoter to drive odp1 expression in cruciferous oilseed plants to increase oil content while maintaining normal germination
10/07/2010US20100257632 Methods for generating marker-free transgenic plants
10/07/2010US20100257631 Soybean variety g00-3209
10/07/2010US20100257630 Plants and seeds of corn variety cv309595
10/07/2010US20100257629 Plants and seeds of corn variety cv508599
10/07/2010US20100257628 Plants and seeds of corn variety cv042972
10/07/2010US20100257627 Plants and seeds of corn variety cv158320
10/07/2010US20100257626 Plants and seeds of corn variety cv860525
10/07/2010US20100257625 Plants and seeds of corn variety cv324581
10/07/2010US20100257624 Plants and seeds of corn variety cv182838
10/07/2010US20100257622 Cos for mechanical harvest
10/07/2010US20100257621 Methods for Hybrid Corn Seed Production and Compositions Produced Therefrom
10/07/2010US20100257620 Transgenic animals for assessing drug metabolsim and toxicity
10/07/2010US20100257619 mTOR Ligands and Polynucleotides Encoding mTOR Ligands
10/07/2010US20100257616 DNA regulatory element for the expression of transgenes in neurons of a subject and uses thereof
10/07/2010US20100256332 GLP-1 Fusion Peptides, Their Production and Use
10/07/2010US20100256226 Eg-vegf nucleic acids and polypeptides and methods of use
10/07/2010US20100256225 Constructs containing multiple expression cassettes for cancer therapy
10/07/2010US20100256223 Oligonucleotides for modulating target rna activity
10/07/2010US20100256222 Micro-rna scaffolds, non-naturally occurring micro-rnas, and methods for optimizing non-naturally occurring micro-rnas
10/07/2010US20100256221 Methods and compositions for treating neuropathic and neurodegenerative conditions
10/07/2010US20100256218 RNAi MODULATION OF MLL-AF4 AND USES THEREOF
10/07/2010US20100256070 Recombinant vibrio cholerae exotoxins
10/07/2010US20100256069 Targeted induction of aggregation of proteins with cross beta structures
10/07/2010US20100256055 Conjugates of neurotensin or neurotensin analogs and uses thereof
10/07/2010US20100256051 Method for protecting cotton plants from boll weevil infestation
10/07/2010US20100256040 Composition and method for treating viral infection
10/07/2010US20100256037 Polypeptides Having Cellobiohydrolase I Activity and Polynucleotides Encoding Same
10/07/2010US20100255608 Isolated grp94 ligand binding domain polypeptide and nucleic acid encoding same, crystalline form of same, and screening methods employing same
10/07/2010US20100255586 Methods and compositions for producing vitamin k dependent proteins
10/07/2010US20100255579 Tumor antigen protein and use thereof
10/07/2010US20100255574 Human Secreted Proteins
10/07/2010US20100255572 Inflammation-induced anti-flammatory gene expression
10/07/2010US20100255570 Polymerase Chain Reaction Product-Cloning Vector Suitable to its Easy Production and Method for Producing the Same
10/07/2010US20100255552 Butanal Production Using Engineered Streptomyces Coelicolor
10/07/2010US20100255550 Regulatory Factors Controlling Oil Biosynthesis In Microalgae And Their Use
10/07/2010US20100255544 Coryneform bacteria which produce chemical compounds ii
10/07/2010US20100255542 Polypeptides having cellulase activity
10/07/2010US20100255539 Engineered Antibody-Stress Protein Fusions
10/07/2010US20100255538 Antibodies to insulin-like growth factor i receptor
10/07/2010US20100255537 Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptide and heterodimer thereof
10/07/2010US20100255535 Novel gene upregulated in cancers of the prostate
10/07/2010US20100255501 Method of identifying a mhc class i restricted t cell response
10/07/2010US20100255495 Methods for predicting the risk of diabetic nephropathy using genetic markers and arrays containing the same
10/07/2010US20100255494 Methods for predicting the risk of diabetic nephropathy using genetic markers and arrays containing the same
10/07/2010US20100255468 Method of assessing gene examination data, program therefor and apparatus of the same
10/07/2010US20100255463 Compositions and methods for sequence determination
10/07/2010US20100255175 Plants and seeds of corn variety cv511443
10/07/2010US20100255075 CR-2 Binding Peptide P28 as Molecular Adjuvant for DNA Vaccines
10/07/2010US20100255056 Fibronectin Type III Domain Based Scaffold Compositions, Methods And Uses
10/07/2010US20100255038 Purified polypeptide comprising or consisting of a c-terminus msp1 antigen from plasmodium falciparum carrying a glycosyl-phosphatidyl-inositol group (gpi)
10/07/2010US20100255037 Novel sequences of haemonchus contortus, immunogenic compositions, methods for preparation and use thereof
10/07/2010US20100255034 Streptococcus Pyogenes Antigens
10/07/2010US20100255031 truncated l1 protein of human papillomavirus type 16
10/07/2010US20100255030 Avirulent, immunogenic flavivirus chimeras
10/07/2010US20100255027 Papilloma pseudovirus and preparation
10/07/2010US20100255023 Dendritic cell vaccine compositions and uses of same
10/07/2010US20100255021 Truncated l1 protein of human papillomavirus type 6
10/07/2010US20100255018 Polynucleotides and polypeptides involved in gestational malaria, and biological applications
10/07/2010US20100255014 Protein Complex Using An Immunoglobulin Fragment and Method For The Preparation Thereof
10/07/2010US20100255013 Glycoprotein compositions
10/07/2010US20100255011 Compositions and methods for modulating the activity of complement regulatory proteins on target cells
10/07/2010US20100255010 Anti-her antibodies
10/07/2010US20100255008 Antibodies against human tweak and uses thereof
10/07/2010US20100255006 Novel molecules of the pyrin/nbs/lrr protein family and uses thereof
10/07/2010US20100255000 Antidotes for factor xa inhibitors and methods of using the same
10/07/2010US20100254999 Eg-vegf nucleic acids and polypeptides and methods of use
10/07/2010US20100254998 Method for prolonging longevity
10/07/2010US20100254993 Human monoclonal antibodies against human il-4
10/07/2010US20100254992 Anti-mcp-1 antibodies, compositions, methods and uses
10/07/2010US20100254987 Engineered proteins with high affinity for dota chelates
10/07/2010US20100254986 Method for making heteromultimeric polypeptides
10/07/2010US20100254982 Cancer specific antibody and cell surface proteins
10/07/2010US20100254978 Antibody molecules having specificity for human ox40
10/07/2010US20100254977 Engineered anti-alpha v-integrin hybrid antibodies
10/07/2010US20100254976 Use of protease nexin 1 inhibitors to reduce metastasis
10/07/2010US20100254975 Alpha-4 beta-7 heterodimer specific
10/07/2010US20100254964 Modified Bouganin Proteins, Cytotoxins and Methods and Uses Thereof
10/07/2010US20100254947 SIMIAN SUBFAMILY B ADENOVIRUSES SAdV-28, -27, -29, -32, -33, AND -35 AND USES THEREOF
10/07/2010US20100254946 Maintenance of hair growth and treatment of hair-loss
1 ... 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 ... 4023